Profile
International Journal of Global Social Work Volume 4 (2021), Article ID 4:IJGSW-117, 3 pages
https://doi.org/10.15344/ijgsw/2021/117
Mini Review
Potentials of Complementary Medicine (CAM) for Mental Health

Sabine Bährer-Kohler

1Invited Professor for Mental Health/ Mental Health & Social Determinants at Tropical Neurology and Neuroinfection Master, International University of Catalonia (UIC), Barcelona, Spain
2Managing Director, Dr. Bährer-Kohler& Partners, Switzerland
3President, Association for Mental Health- Global Mental Health, Switzerland
4Chair, Houses of Health, Switzerland
Prof. Dr. Sabine Bährer-Kohler, Mental Health & Social, Determinants at Tropical Neurology and Neuroinfection Master, International University of Catalonia (UIC), Barcelona, Spain, Tel: +41 (0) 61 5513059; E-mail: sabine.baehrer@datacomm.ch
17 May 2021; 29 May 2021; 31 May 2021
Bährer-Kohler S (2021) Potentials of Complementary Medicine (CAM) for Mental Health. Int J Global Soc Work 4: 117. doi: https://doi.org/10.15344/ijgsw/2021/117

Abstract

Mental disorders such as anxiety disease or depression are among the strongest contributors to the global burden of disease with impacts on health and major social, human rights and economic consequences. Gender is a contributing determinant of mental health and mental diseases.

Complementary and alternative medicine (CAM) can be an effective additional intervention form to support and to heal patients in the context of mental health diseases; although some results of research on CAM can be inconclusive. Further research about CAM treatments is needed.


1. Introduction

Approximately 450 million people are affected by psychiatric disorders worldwide [1,2]. Mental disorders are among the strongest contributors to the global burden of disease with impacts on health and major social, human rights and economic consequences [3-5]. Nearly one third (31.7%) of people who suffer major psychiatric disorders end up with a long-term dependency and disability [6,7].

COVID-19 is hereby an amplifier, cf. the EU- High-Level Conference on 10th May 2021 in Brussels.

Many studies have shown that conventional therapies for mental disorders are not always effective [8,9].

Gender aspects occur particularly in the rates of common mental disorders - depression, anxiety and somatic complaints [10]. Statista [11] published the percentage of the global population who suffer from select mental health or substance use disorders by gender;

  1. 13.3% of any mental or substance use disorder are female and 12.6% male,
  2. 4.1% of women suffer from depression, compared to 2.7% of men, and
  3. anxiety disorders are represented by 4.7% females and 2.8% males.

Leading mental health diseases of older adults are depression, organic brain syndromes and dementias, a majority of these sufferers are women [10].

CAM (complementary and alternative medicine) has been utilized for mental diseases. The US National Institutes of Health (NIH) stated that CAM consists of “a group of diverse medical and healthcare systems, practices and products that are not presently considered to be part of conventional medicine” [12]. CAM medicine include e.g., acupuncture, herbal medicine, homeopathy, and Traditional Chinese Medicine (TCM).

Often, complementary systems of medicine themselves encompass a range of practices which are commonly embedded within contextual cultural milieu, community beliefs, based on different historical traditions; CAM can hereby be less culture-specific [13].

2. Content

Current research suggests that a large and possibly growing number of people around the world use complementary and alternative medicine [4,14].

The CAM prevalence across the EU member states remains unclear due to the heterogeneity of studies, nevertheless the European Information Centre for Complementary & Alternative Medicine (EICCAM) suggest that more than 100 million EU citizens are regular users of CAM [15]. The use of CAM has increased in Western Countries over the last 25 years and this has been documented in the US and in the UK [16] and Germany with the epidemiological, economic and political importance of public health. Studies from the UK reported about the prevalence of CAM use by country between 6-71%, in Germany between 4.6-62%, and in Italy 16-84% [15, p.20].

Complementary and alternative medicine is so far not part of conventional medicine as practiced by medical doctors and allied health professionals, but is still part of how to deal with health problems and disorders, including mental disorders [9,17,18].

Data on CAM consultations vary across countries, mental disorders and their severity [9].

A current analysis documented that 6.4% of Singaporeans have used at least one form of CAM in the past 12 months for their mental illness [19].

In the US, significantly more people with moderate mental diseases reported the use of CAM when compared with the general population [20] and the use of CAM is more than twice as common among youth with mental health concerns as those without (28.9% vs. 11.6%, [21].

Anxiety and mood disorders, in particular, have been associated with increased CAM use, respectively an extensive use (43%) [22]. Also, Ng et al. [23], Freeman et al. [24], and Qureshi et al. [25] underlined that depression remains a condition where the prevalence of CAM use across patients is very high.

Ng et al. [23] documented, based on Qureshi et al. [25], that there are alone over 120 CAM therapies that purportedly help treat depression or relieve depressive symptoms, e.g., herbal remedies which include St. John’s wort.

Haller et al. [29] and Luberto et al. [30] underlined that while some complementary or alternative therapies have become an adjunct in the standard treatment of depression, others are known for their possible side effects or interactions with standard drugs. But side effects are not new in this context - for example for antipsychotic drug use and the possible increased risk of strokes [31,32].

Recent clinical practice guidelines with a more comprehensive overview for the treatment of patients with major depressive disorders exist, for example from the American Psychiatric Association (APA). They concluded “however, there are still many unanswered questions about optimizing and individualizing treatment” [33, p.100], but these statements also apply to tailored treatments with a generalistic approach, holistic and patient-centered [34].

3. Conclusion

Worldwide, the amount of research on CAM has increased, nevertheless some results can be inconclusive (Institute of Medicine (U.S.) [35]). Further research about CAM treatment is needed [29]. Nevertheless, in the coming decades advances in conventional biomedicine will take in place in parallel with non-conventional therapies [36].

Competing Interests

The author declare that there is no competing interests regarding the publication of this article.


References

  1. Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, et al. (2018) Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: a protocol for a systematic review. Syst Rev 7: 10. View
  2. World Bank Group and WHO (2016) Out of the shadows: making mental health a global development priority organized by World Bank Group & WHO, April 13–14. Washington D.C; 2016. (Retrieved 11.5.21). View
  3. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, et al. (2013) Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. The Lancet 382: 1575-1586. View
  4. Wemrell M, Olsson A, Landgren K (2020) The Use of Complementary and Alternative Medicine (CAM) in Psychiatric Units in Sweden. Issues Ment Health Nurs 41: 946-957. View
  5. World Health Organization (2021a) Mental disorders. Key facts. (Retrieved: 11.5.21). View
  6. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002–2030. PLoS Med 3: e442. View
  7. Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, et al. (2020) Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and metaanalysis. Syst Rev 9: 17. View
  8. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine 358: 252-260. View
  9. De Jonge P, Wardenaar KJ, Hoenders HR, Evans-Lacko S, et al. (2018) Complementary and alternative medicine contacts by persons with mental disorders in 25 countries: Results from the world mental health surveys. Epidemiol Psychiatr Sci 27: 552-567. View
  10. World Health Organization (2021b) Gender and women's mental health. (Retrieved 7.5.21). View
  11. Statista (2021) Percentage of the global population that suffers from select mental health or substance use disorders as of 2017, by gender. (Retrieved 10.5.21). View
  12. National Center for Complementary and Alternative Medicine-NCCAM (2006) What is complementary and alternative medicine (CAM)? The National Center for Complementary and Integrative Health (NCCIH).
  13. Gureje O, Nortje G, Makanjuola V, Oladeji B, Seedat S, et al. (2015) The role of global traditional and complementary systems of medicine in treating mental health problems. Lancet Psychiatry 2: 168-177. View
  14. Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL (2015) Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl Health Stat Report 10: 1-16. View
  15. Eardley S, Bishop FL, Prescott P, Cardini F, Brinkhaus B, et al. (2012) CAM use in Europe-The patients’perspective. Final Report of CAMbrella Work Package 4. (Retrieved 11.5.21).
  16. Hunt KJ, Coelho F, Wider B, Perry R, Hung SK, et al. (2010) Complementary and alternative medicine use in England: results from a national survey. Int J Clin Pract 64:1496-1502. View
  17. Kessler RC, Davis RB, Foster DF, Van Rompay M I, Walters EE, et al. (2001a) Long-term trends in the use of complementary and alternative medical therapies in the United States. Annals of Internal Medicine 135: 262-268. View
  18. Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, et al. (2001b) The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 158: 289-294. View
  19. Seet V, Abdin E, Vaingankar JA, Shahwan S, Chang S, et al. (2020) The use of complementary and alternative medicine in a multi- ethnic Asian population: results from the 2016 Singapore Mental Health Study. BMC Complement Med The 20: 52. View
  20. Rhee TG, Evans RL, McAlpine DD, Johnson PJ (2017) Racial/ethnic differences in the use of complementary and alternative medicine in US adults with moderate mental distress: results from the 2012 National Health Interview Survey. J Prim Care Community Health 8: 43-54. View
  21. Kemper KJ, Gardiner P, Birdee GS (2013) Use of complementary and alternative medical therapies among youth with mental health concerns. Acad Pediatr 13: 540-545. View
  22. Bystritsky A, Hovav S, Sherbourne C, Stein MB, Rose RD, et al. (2012). Use of complementary and alternative medicine in a large sample of anxiety patients. Psychosomatics 53: 266-72. View
  23. Ng JY, Nazir Z, Nault H (2020) Complementary and alternative medicine recommendations for depression: a systematic review and assessment of clinical practice guidelines. BMC Complement Med Ther 20: 299. View
  24. Freeman MP, Fava M, Lake J, Trivedi MH, Wisner KL, et al. (2010) Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association task force report. J Clin Psychiatry, 71: 669-681. View
  25. Qureshi NA, Al-Bedah AM (2013) Mood disorders and complementary and alternative medicine: a literature review. Neuropsychiatr Dis Treat 9: 639- 658. View
  26. Ng QX, Venkatanarayanan N, Xian Ho CY (2017a) Clinical use of hypericum perforatum (St John’s wort) in depression: a meta-analysis. J Affect Disord 210: 211-221. View
  27. Ng QX, Koh SSH, Chan HW, Ho CYX (2017b) Clinical use of curcumin in depression: a meta-analysis. J Am Med Dir Assoc 18: 503-508. View
  28. Ashraf H, Salehi A, Sousani M, Sharifi MH (2021) Use of Complementary Alternative Medicine and the Associated Factors among Patients with Depression. Evid Based Complement Alternat Med. 2021: 6626394. View
  29. Haller H, Anheyer D, Cramer H, Dobas G (2019) Complementary therapies for clinical depression: an overview of systematic reviews. BMJ Open, 9: e028527. View
  30. Luberto CM, White C, Sears RW, Cotton S (2013) Integrative medicine for treating depression: an update on the latest evidence. Curr Psychiatry Rep 15: 391. View
  31. Zivkovic S, Koh CH, Kaza N, Jackson CA (2019) Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and metaanalysis. BMC Psychiatry 19: 189. View
  32. Correll CU, Joffe BI, Rosen LM, Sullivan TB, Joffe RT (2015) Cardiovascular and cerebrovascular risk factors and events associated with secondgeneration antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study. World Psychiatry 14: 56-63. View
  33. APA- American Psychiatric Association (2010) Practice guideline for the treatment of patients with major depressive disorder. Washington, DC: American Psychiatric Association.
  34. Hashim MJ (2019) The Art of Healing - Core Values and Goals of Medicine, Nursing and Healthcare. J Coll Physicians Surg Pak 29: 299-300. View
  35. Institute of Medicine (U.S.) Committee on the Use of Complementary and Alternative Medicine by the American Public (2005). Complementary and alternative medicine in the United States. National Academies Press.
  36. Lake J (2012) The Future of Mental Health Care Toward an Integrative Paradigm. In book: Mental Illnesses - Evaluation, Treatments and Implication. View